| 发明名称 |
VEGF Neutralizing Prodrugs for the Treatment of Ocular Conditions |
| 摘要 |
The present invention relates to a pharmaceutical composition comprising one or more pharmaceutically acceptable excipient(s) and a VEGF neutralizing prodrug, which comprises a VEGF neutralizing biologically active moiety, for use in a method for the treatment of one or more ocular conditions. |
| 申请公布号 |
US2015297740(A1) |
申请公布日期 |
2015.10.22 |
| 申请号 |
US201314435350 |
申请日期 |
2013.10.08 |
| 申请人 |
Ascendis Pharma Ophthalmology Division A/S |
发明人 |
RAU Harald;KNAPPE Thomas;Laufer Burkhardt;REIMANN Romy;WEISBROD Samuel;SPROGØE Kennett;BISEK Nicola;STARK Sebastian;VOIGT Tobias |
| 分类号 |
A61K47/48;A61K9/00;A61K45/06;C07K16/22;A61K39/44 |
主分类号 |
A61K47/48 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
1. A method for the treatment of one or more ocular conditions, the method comprising:
administering a pharmaceutical composition comprising:
one or more pharmaceutically acceptable excipient(s); anda VEGF neutralizing prodrug comprising a covalently bound VEGF neutralizing biologically active moiety. |
| 地址 |
Hellerup DK |
